Thursday, May 05, 2016 2:50:22 PM
The company, knowing that one major problem which may compromise trial is that the pseudo progression patients are potentially regarded as true progression patients, particularly the mesenchymal subtype of patients (referred to Prins and LL's related papers and videos).
As a result, it voluntarily stopped new patient screening at a time it thought those patients already in the pipeline were enough to get it over to the targeted 348 patient enrolments while submitting information to regulatory agencies (simply referred to FDA below as representative of all three involved agencies). The information submitted contains way to resolve this issue, and asking retrospections of all suspicious cases.
FDA agreed and asked the company to remain at the partial screening halt until further notice after receiving the request and information from the company – now the trial is fully under the control of FDA (an alternative to the hijacking theory).
Dialog has been ongoing back and forth between the company and FDA. On the one hand, FDA may want to make sure the method proposed by the company is indeed trustworthy, scientifically and empirically based (to have a kind of a small trial within the trial to see there is statistically significance so that it can validate the method proposed by the company). This takes lots of time, so six to seven months have passed.
Recently, FDA may have had some data and observed the correlations in which the company has long believed are with merit. It would then ask the company for some further information. As a result, I highly suspect that the company has so far submitted all the relevant information (such as biological assays of all the related or suspected patients before and after the partial halt) to the FDA.
FDA could be in the final validating process now. If it is persuaded, all PFS events will be recounted, which is strongly in the company's favor; if it is not persuaded, anything will be determined as it stands today, or according to the protocol.
I strongly believe and hope FDA will take a scientific, rational and reasonable stance and let the data have the final say.
In the meantime, the 1st and/or 2nd interim analysis events may have been reached, and the analyses may have been conducted with definite analysis data.
Please allow me to conclude with this: It is either $1.xx or $30. You choose, and most importantly, God bless patients to have an effective treatment, and those who believe!
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM